1. Rizza ERH, DiGiovanna JJ, Khan SG, Tamura D, Jeskey JD, Kraemer KH. Xeroderma pigmentosum: a model for human premature aging. J Invest Dermatol. 2021;141(4S):976-984.
2. Ueda T, Kanda F, Nishiyama M, Nishigori C, Toda T. Quantitative analysis of brain atrophy in patients with xeroderma pigmentosum group a carrying the founder mutation in Japan. J Neurol Sci. 2017;381:103-106.
3. Imoto K, Nadem C, Moriwaki S, et al. Ancient origin of a Japanese xeroderma pigmentosum founder mutation. J Dermatol Sci. 2013;69(2):175-176.
4. Nishigori C, Nakano E, Masaki T, et al. Characteristics of Xeroderma Pigmentosum in Japan: lessons from two clinical surveys and measures for patient care. Photochem Photobiol. 2019;95(1):140-153.
5. Nishigori C, Moriwaki S, Takebe H, Tanaka T, Imamura S. Gene alterations and clinical characteristics of xeroderma pigmentosum group a patients in Japan. Arch Dermatol. 1994;130(2): 191-197.
6. Tsuji Y, Ueda T, Sekiguchi K, et al. Progressive length-dependent polyneuropathy in xeroderma pigmentosum group a. Muscle Nerve. 2020;62(4):534-540.
7. Brooks PJ. The case for 8,5′- cyclopurine- 2′- deoxynucleo sides as endogenous DNA lesions that cause neurodegeneration in xeroderma pigmentosum. Neuroscience. 2007;145(4):1407-1417.
8. Kuraoka I, Robins P, Masutani C, et al. Oxygen free radical damage to DNA. Translesion synthesis by human DNA polymerase eta and resistance to exonuclease action at cyclopurine deoxynucleoside residues. J Biol Chem. 2001;276(52):49283-49288.
9. Mori T, Nakane H, Iwamoto T, et al. High levels of oxidatively generated DNA damage 8,5′-cyclo-2′-deoxyadenosine accumulate in the brain tissues of xeroderma pigmentosum group a gene-knockout mice. DNA Repair (Amst). 2019;80:52-58.
10. Fang EF, Scheibye-Knudsen M, Brace LE, et al. Defective mitophagy in XPA via PARP-1 hyperactivation and NAD(+)/SIRT1 reduction. Cell. 2014;157(4):882-896.
11. Manandhar M, Lowery MG, Boulware KS, Lin KH, Lu Y, Wood RD. Transcriptional consequences of XPA disruption in human cell lines. DNA Repair (Amst). 2017;57:76-90.
12. Lauffenburger DA, Horwitz AF. Cell migration: a physically integrated molecular process. Cell. 1996;84(3):359-369.
13. Hwang HM, Ku RY, Hashimoto-Torii K. Prenatal environment that affects neuronal migration. Front Cell Dev Biol. 2019;7:138.
14. Yu JY, DeRuiter SL, Turner DL. RNA interference by expression of short-interfering RNAs and hairpin RNAs in mammalian cells. Proc Natl Acad Sci U S A. 2002;99(9):6047-6052.
15. Nagano T, Morikubo S, Sato M. Filamin a and FILIP (Filamin A-interacting protein) regulate cell polarity and motility in neocortical subventricular and intermediate zones during radial migration. J Neurosci. 2004;24(43):9648-9657.
16. Ogawa H, Koyanagi-Aoi M, Otani K, Zen Y, Maniwa Y, Aoi T. Interleukin-6 blockade attenuates lung cancer tissue construction integrated by cancer stem cells. Sci Rep. 2017;7(1):12317.
17. Tanioka M, Budiyant A, Ueda T, et al. A novel XPA gene mutation and its functional analysis in a Japanese patient with xeroderma pigmentosum group a. J Invest Dermatol. 2005;125(2):244-246.
18. Arseni L, Lanzafame M, Compe E, et al. TFIIH-dependent MMP-1 overexpression in trichothiodystrophy leads to extracellular matrix alterations in patient skin. Proc Natl Acad Sci U S A. 2015;112(5):1499-1504.
19. Le May N, Mota-Fernandes D, Velez-Cruz R, Iltis I, Biard D, Egly JM. NER factors are recruited to active promoters and facilitate chromatin modification for transcription in the absence of exogenous genotoxic attack. Mol Cell. 2010;38(1):54-66.
20. Cimini A, Benedetti E, Cristiano L, et al. Expression of peroxisome proliferator-activated receptors (PPARs) and retinoic acid receptors (RXRs) in rat cortical neurons. Neuroscience. 2005;130(2):325-337.
21. Luo T, Wagner E, Drager UC. Integrating retinoic acid signaling with brain function. Dev Psychol. 2009;45(1):139-150.
22. Choi J, Park S, Sockanathan S. Activated retinoid receptors are required for the migration and fate maintenance of subsets of cortical neurons. Development. 2014;141(5):1151-1160.
23. Anttinen A, Koulu L, Nikoskelainen E, et al. Neurological symptoms and natural course of xeroderma pigmentosum. Brain. 2008;131(Pt 8):1979-1989.